Literature DB >> 19899010

Correlation of pretreatment polarographically measured oxygen pressures with quantified contrast-enhanced power doppler ultrasonography in spontaneous canine tumors and their impact on outcome after radiation therapy.

Carla Rohrer Bley1, Dagmar Laluhova, Malgorzata Roos, Barbara Kaser-Hotz, Stefanie Ohlerth.   

Abstract

PURPOSE: To evaluate the use of noninvasive quantified contrast-enhanced power Doppler ultrasonography as a surrogate in the estimation of tumor hypoxia measured by invasive pO(2) histography in canine tumors.
MATERIAL AND METHODS: Data of pretreatment tumor oxygenation status, tumor vascularity and blood volume, and tumor response after radiation therapy was collected in 48 spontaneous malignant oral tumors (Table 1). Tumor oxygenation status was correlated to vascularity and blood volume, and influences on outcome after treatment were analyzed.
RESULTS: Although vascularity and blood volume correlated moderately with median pO(2) (r = 0.51 and 0.61; p = 0.001 and < 0.0001) and percentage of pO(2) readings < or = 2.5, 5, and 10 mmHg (r = -0.37 to -0.42; p < 0.01-0.03) for all tumors, they did not correlate within the different histology groups (p = 0.06-0.9). For all tumors, pretreatment oxygenation status, vascularity and blood volume were not found to be of prognostic value (Tables 2 and 3).
CONCLUSION: These analyses show that quantified contrast-enhanced power Doppler ultrasonography does not represent a noninvasive indirect method to assess tumor hypoxia measured by invasive pO(2) histography. Both technologies were nonprognostic indicators in spontaneous malignant canine oral tumors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19899010     DOI: 10.1007/s00066-009-1988-6

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  44 in total

1.  Efficacy of radiation therapy for the treatment of macroscopic canine oral soft tissue sarcoma.

Authors:  Valérie J Poirier; Carla Rohrer Bley; Malgorzata Roos; Barbara Kaser-Hotz
Journal:  In Vivo       Date:  2006 May-Jun       Impact factor: 2.155

2.  Radiotherapy of oral malignant melanomas in dogs.

Authors:  L Blackwood; J M Dobson
Journal:  J Am Vet Med Assoc       Date:  1996-07-01       Impact factor: 1.936

3.  Prognostic value of high-frequency sonography and color Doppler sonography for the preoperative assessment of melanomas.

Authors:  N Lassau; S Mercier; S Koscielny; M F Avril; A Margulis; G Mamelle; P Duvillard; J Leclère
Journal:  AJR Am J Roentgenol       Date:  1999-02       Impact factor: 3.959

4.  Small hepatocellular carcinoma: differentiation from adenomatous hyperplasia with color Doppler US and dynamic Gd-DTPA-enhanced MR imaging.

Authors:  R Lencioni; M Mascalchi; D Caramella; C Bartolozzi
Journal:  Abdom Imaging       Date:  1996 Jan-Feb

5.  Preoperative assessment of vascularity by color Doppler ultrasonography in human rectal carcinoma.

Authors:  O Ogura; Y Takebayashi; T Sameshima; S Maeda; K Yamada; K Hata; S Akiba; T Aikou
Journal:  Dis Colon Rectum       Date:  2001-04       Impact factor: 4.585

6.  A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy.

Authors:  M Nordsmark; J Overgaard
Journal:  Radiother Oncol       Date:  2000-10       Impact factor: 6.280

7.  pO(2) Polarography versus positron emission tomography ([(18)F] fluoromisonidazole, [(18)F]-2-fluoro-2'-deoxyglucose). An appraisal of radiotherapeutically relevant hypoxia.

Authors:  Bernd Gagel; Patrick Reinartz; Ercole Dimartino; Michael Zimny; Michael Pinkawa; Payam Maneschi; Sven Stanzel; Kurt Hamacher; Heinz H Coenen; Michael Westhofen; Ulrich Büll; Michael J Eble
Journal:  Strahlenther Onkol       Date:  2004-10       Impact factor: 3.621

8.  Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix.

Authors:  M Höckel; C Knoop; K Schlenger; B Vorndran; E Baussmann; M Mitze; P G Knapstein; P Vaupel
Journal:  Radiother Oncol       Date:  1993-01       Impact factor: 6.280

9.  Prognostic impact of HIF-1alpha expression in patients with definitive radiotherapy for cervical cancer.

Authors:  Kathrin Dellas; Matthias Bache; Steffi U Pigorsch; Helge Taubert; Matthias Kappler; Daniel Holzapfel; Ester Zorn; Hans-Juergen Holzhausen; Gabriele Haensgen
Journal:  Strahlenther Onkol       Date:  2008-03       Impact factor: 3.621

10.  Correlation of quantified contrast-enhanced power Doppler ultrasonography with immunofluorescent analysis of microvessel density in spontaneous canine tumours.

Authors:  Stefanie Ohlerth; Melanie Wergin; Carla Rohrer Bley; Francesca Del Chicca; Dagmar Laluhová; Beat Hauser; Malgorzata Roos; Barbara Kaser-Hotz
Journal:  Vet J       Date:  2008-10-14       Impact factor: 2.688

View more
  6 in total

1.  Prognostic impact of hemoglobin level and other factors in patients with high-grade gliomas treated with postoperative radiochemotherapy and sequential chemotherapy based on temozolomide: a 10-year experience at a single institution.

Authors:  Giampiero Ausili Céfaro; Domenico Genovesi; Annamaria Vinciguerra; Marianna Trignani; Maria Taraborrelli; Antonietta Augurio; Roberto Buonaguidi; Renato J Galzio; Marta Di Nicola
Journal:  Strahlenther Onkol       Date:  2011-11-25       Impact factor: 3.621

2.  Prognostic value of radiobiological hypoxia during fractionated irradiation for local tumor control.

Authors:  Daniel Zips; Simon Böke; Theresa Kroeber; Andreas Meinzer; Kerstin Brüchner; Howard D Thames; Michael Baumann; Ala Yaromina
Journal:  Strahlenther Onkol       Date:  2011-04-26       Impact factor: 3.621

3.  Quantitative assessment of hypoxia subtypes in microcirculatory supply units of malignant tumors using (immuno-)fluorescence techniques.

Authors:  Constantin-Alin Maftei; Christine Bayer; Kuangyu Shi; Sabrina T Astner; Peter Vaupel
Journal:  Strahlenther Onkol       Date:  2011-03-24       Impact factor: 3.621

4.  Hypoxia-Related Marker GLUT-1, CAIX, Proliferative Index and Microvessel Density in Canine Oral Malignant Neoplasia.

Authors:  Valeria Meier; Franco Guscetti; Malgorzata Roos; Stefanie Ohlerth; Martin Pruschy; Carla Rohrer Bley
Journal:  PLoS One       Date:  2016-02-23       Impact factor: 3.240

5.  Results of Dynamic Contrast-Enhanced Ultrasound Correlate With Treatment Outcome in Canine Neoplasia Treated With Electrochemotherapy and Interleukin-12 Plasmid Electrotransfer.

Authors:  Maja Brloznik; Simona Kranjc Brezar; Nina Boc; Tanja Knific; Maja Cemazar; Nina Milevoj; Gregor Sersa; Natasa Tozon; Darja Pavlin
Journal:  Front Vet Sci       Date:  2021-05-20

6.  Tumor perfusion evaluation using dynamic contrast-enhanced ultrasound after electrochemotherapy and IL-12 plasmid electrotransfer in murine melanoma.

Authors:  Maja Brloznik; Nina Boc; Maja Cemazar; Gregor Sersa; Masa Bosnjak; Simona Kranjc Brezar; Darja Pavlin
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.